Amgen Inc (AMGN):企業の財務・戦略的SWOT分析

◆英語タイトル:Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1333
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amgen Inc (AMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to treat patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by direct-to-consumer channels such as print, television and online media. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Apr 02,2020: Amgen and Adaptive Biotechnologies announce strategic partnership to develop a therapeutic to prevent or treat COVID-19
Mar 31,2020: Amgen establishes wholly-owned affiliate In Japan
Mar 31,2020: Amgen update regarding COVID-19 for media
Mar 28,2020: Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol
Mar 23,2020: Amgen and The Amgen Foundation commit up to $12.5 million to support COVID-19 relief efforts

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amgen Inc – Key Facts
Amgen Inc – Key Employees
Amgen Inc – Key Employee Biographies
Amgen Inc – Major Products and Services
Amgen Inc – History
Amgen Inc – Company Statement
Amgen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Amgen Inc – Business Description
Business Segment: Human Therapeutics
Overview
Performance
Key Stats
Business Segment: Other Revenues
Overview
Performance
Geographical Segment: Rest of the world (ROW)
Performance
Geographical Segment: United States
Performance
R&D Overview
Amgen Inc – Corporate Strategy
Amgen Inc – SWOT Analysis
SWOT Analysis – Overview
Amgen Inc – Strengths
Amgen Inc – Weaknesses
Amgen Inc – Opportunities
Amgen Inc – Threats
Amgen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Amgen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2020: Amgen and Adaptive Biotechnologies announce strategic partnership to develop a therapeutic to prevent or treat COVID-19
Mar 31, 2020: Amgen update regarding COVID-19 for media
Feb 21, 2020: Leaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs
Jan 30, 2020: Amgen reports fourth quarter and full year 2019 financial results
Dec 09, 2019: Amgen selects location for R&D facility in the South San Francisco Biotechnology Hub
Dec 09, 2019: BioMed Realty welcomes Amgen to its Gateway of Pacific Campus
Dec 05, 2019: Novartis and Amgen submit industry datasets to ASH RC Data Hub
Dec 05, 2019: Amgen gift to fund launch of KGI Center for Training in Applied Genomics
Nov 05, 2019: Revolution Medicines and Amgen to trial cancer drug combination
Nov 01, 2019: Amgen to acquire stake in BeiGene for $2.7bn
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amgen Inc, Key Facts
Amgen Inc, Key Employees
Amgen Inc, Key Employee Biographies
Amgen Inc, Major Products and Services
Amgen Inc, History
Amgen Inc, Other Locations
Amgen Inc, Subsidiaries
Amgen Inc, Joint Venture
Amgen Inc, Key Competitors
Amgen Inc, Ratios based on current share price
Amgen Inc, Annual Ratios
Amgen Inc, Annual Ratios (Cont...1)
Amgen Inc, Annual Ratios (Cont...2)
Amgen Inc, Interim Ratios
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Amgen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Amgen Inc, Performance Chart (2015 - 2019)
Amgen Inc, Ratio Charts
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Amgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Amgen Inc (AMGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GAIL (India) Ltd (GAIL):石油・ガス:M&Aディール及び事業提携情報
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company. It carries out processing, transmission and marketing of gas; transmission of liquefied petroleum gas (LPG); re-gasification of liquefied natural gas (LNG); and production and marketing of petrochemicals. The company also has pr …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Brink’s Company (BCO):企業の財務・戦略的SWOT分析
    The Brink's Company (BCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tallink Grupp AS:企業の戦略・SWOT・財務情報
    Tallink Grupp AS - Strategy, SWOT and Corporate Finance Report Summary Tallink Grupp AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Doosan Corporation:企業の戦略・SWOT・財務情報
    Doosan Corporation - Strategy, SWOT and Corporate Finance Report Summary Doosan Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ivenix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ivenix Inc (Ivenix), formerly Fluidnet Corp is a medical technology company that offers infusion therapy solutions. The company offers products such as IV smart pumps and intravenous drug infusion pump systems. Its IV smart pumps eliminate air from fluid bag and IV lines to reduce number of …
  • MDNA Life Sciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Acarix AS-医療機器分野:企業M&A・提携分析
    Summary Acarix A/S (Acarix) is a medical device company that offers design and development of non-invasive cardiac screening products. The company offers non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score on th …
  • The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Norwegian Energy Company ASA:企業のM&A・事業提携・投資動向
    Norwegian Energy Company ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwegian Energy Company ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TBG Diagnostics Ltd (TDL):製薬・医療:M&Aディール及び事業提携情報
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, …
  • Massarella Catering Group Ltd.:企業の戦略・SWOT・財務分析
    Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pear Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • Central Garden & Pet Co (CENT):企業の財務・戦略的SWOT分析
    Central Garden & Pet Co (CENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Applied Industrial Technologies, Inc.:企業の戦略・SWOT・財務情報
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tanner Pharma Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tanner Pharma Group Inc (Tanner Pharma), a subsidiary of Bourne Capital Partners LLC, is a pharmaceutical services company which offers distribution, licensing and commercialization of health care products. The company offers clinical trial sourcing solutions, regulatory affairs management a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆